Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...
Trulicity is a type of biologic drug. To find out whether Ozempic or Trulicity is available as a generic or biosimilar, see the list below. The Food and Drug Administration (FDA) approves ...
South Korea’s Celltrion (Kosdaq: 068270) has announced the US launch of Steqeyma (ustekinumab-stba), a biosimilar to Stelara ...
Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...
Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...
Hosted on MSN20d
J&J sues Samsung Bioepis over Stelara biosimilarThat changed when CVS Health removed Humira from its list of covered drugs and more patients switched to a biosimilar in three weeks than had in the prior 15 months. CVS, which owns a pharmacy benefit ...
Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... sometimes force diabetics to ration their use of the drugs. Semglee's latest approval follows the publication ...
The FDA has approved two new biosimilars of denosumab for all indications of the reference medications Prolia and Xgeva, ...
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results